Calgary, Alberta – TheNewswire - January 14, 2025 -  nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTCQB:NDATF) is pleased to announce the AI-based calibration of its CMCP-5 Anxiety assesssment algorithm. As with the previously-announced depression algorithm, this development allows accurate assessments without real-time machine-learning processing thereby simplifying migration to third-party applications (such as Electronic Medical Records) while reducing processing costs. The anxiety assessment algorithm and previously-announced depression assessment algorithm are now being migrated to the Google Cloud. These developments will allow physicians and therapists to directly compare depression and anxiety predispositions/probabilities when coming to diagnostic and treatment decisions.

James Durward, President, commented, “Anxiety and Depression are the top two mental disorders in the US and Canada. These disorders commonly co-exist, often resulting in mis/overdiagnosis with follow-on misprescription and poor patient outcomes. The ability to differentiate between depression and anxiety is fundamental to better patient outcomes. This is one of the biggest problems in mental health, so it is our top priority.”

The anxiety and depression algorithms referred to above are a subset of the Corporation’s CMCP-5 (formerly “YMI”) predictive mental condition suite.

For Further Information, please contact:

Jim Durward, President

Email: jimd@ndatalyze.com    

nDatalyze Website: https://www.ndatalyze.com      

About CMCP-5: CMCP-5 uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a better understanding of how mental health develops, and how to improve mental wellbeing. CMCP-5 combines expert-guided machine-learning with a proprietary Reference Database to predict an individual’s predisposition toward a variety of common mental conditions, both current and forward in time. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies, and targeting key markets, CMCP-5 aligns societal impact with financial success.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.